Search - tctmd.com

Displaying 1 - 20 of 78

Sort: Relevancy | Date

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Daily News

WHO Endorses Treating Obesity in Adults With GLP-1s

Todd Neale

December 01, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

News Daily News

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Michael O'Riordan

August 02, 2024

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Daily News

New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO

Todd Neale

November 30, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

Advertisement

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

WHO Endorses Treating Obesity in Adults With GLP-1s

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

LDL Control Remains Poor in CAD Patients: NHANES

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Only Half of Revascularized PAD Patients Receive GDMT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content